Home・Stock List・Bio-Rad Laboratories Inc

Bio-Rad Laboratories Inc

Open

SectorHealthcare

325.19 -0.68

Buy Sell

Overview

Share price change

24h

Current

Min

317.48

Max

327.64

Key metrics
By Trading Economics
Income	-731M -11M
Sales	-101M 592M
P/E Sector Avg	52.647 64.641
EPS	1.89
Profit margin	-1.858
Employees	7,450
EBITDA	-751M -637M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	-7.67% downside

Dividends
By Acuity
Next Earnings	4 Aug 2026

Market Stats
By TradingEconomics
Market Cap	710M 8.5B
Previous open	325.87
Previous close	325.19

News Sentiment

By Acuity

50%

162 / 340 Healthcare

Bio-Rad Laboratories Inc Chart

Past performance is not a reliable indicator of future results.

Related News

30 Jul 2026, 20:09 UTC

Bio Rad Laboratories shares are trading roughly flat amid mixed economic signals, including lower-than-expected U.S. GDP growth and rising initial jobless claims.

29 Jul 2026, 18:01 UTC

Bio Rad Laboratories Inc shares are lower today, continuing a decline since Tuesday's close. The broader market reacts to rising crude oil prices and inflation concerns.

28 Jul 2026, 17:03 UTC

Bio Rad Laboratories Inc. shares are higher today, diverging from a declining Nikkei 225 Index amid concerns over tech stock sustainability and rising semiconductor production in China.

27 Jul 2026, 19:46 UTC

Bio Rad Laboratories Inc shares are higher today, reaching a session high as crude oil prices decline. No specific company news was identified.

24 Jul 2026, 19:11 UTC

Bio Rad Laboratories Inc shares are lower, impacted by declines in the Life Sciences Tools & Services sub-sector. Earlier, they rebounded from a session low.

23 Jul 2026, 20:03 UTC

Correlated Moves

Bio Rad Laboratories Inc shares are higher, supported by gains in the Life Sciences Tools & Services sector and positive sentiment from Thermo Fisher Scientific Inc.

22 Jul 2026, 20:07 UTC

Bio Rad Laboratories Inc shares are higher today, maintaining a position above their 20-day moving average and near the upper end of their one-month range.

21 Jul 2026, 16:26 UTC

News

Bio-Rad Laboratories Inc shares are lower amid negative sentiment surrounding Sartorius, which reported disappointing earnings from Danaher’s bioprocessing unit.

20 Jul 2026, 19:17 UTC

Correlated Moves

BIO shares lower; iShares U.S. Healthcare ETF declines during session.

Peer Comparison

Price change

Bio-Rad Laboratories Inc Forecast

Price Target

By TipRanks

-7.67% downside

12 Months Forecast

Average 301.67 USD -7.67%

High 320 USD

Low 275 USD

Based on 3 Wall Street analysts offering 12 month price targets forBio-Rad Laboratories Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

3 ratings

Buy

Hold

Sell

Based on 3 analysts giving stock ratings to Bio-Rad Laboratories Inc - Dist in the past 3 months.

Sentiment

By Acuity

162 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.